Individuals Discontinuing Anti-Obesity Injections Put On Pounds Far More Rapidly Compared to Dieters
Fresh analysis indicates that individuals who discontinue new slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise plans.
Published data in a prominent medical journal demonstrates that while overweight individuals often shed about a fifth of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"People using these treatments need to be cognizant of the danger of rapid rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to original mass within about 18 months.
Comparing Therapies
The analysis, which looked at dozens of studies involving over 9,000 of patients, compared the effects of the injectable medications with conventional dieting.
Scientists emphasize that people who lose weight through diet and exercise typically experience a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.
Explaining the Rapid Regain
Doctors propose the mechanism of the drugs is key to understanding the amplified weight return.
The injections imitate a body's own chemical called GLP-1, which moderates hunger.
"Artificially providing GLP-1 concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement results in hunger is uncontrolled, making binge eating far more likely."
An Ongoing Issue?
The NHS suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, due to the likelihood of weight regain, the treatment is often ongoing.
This opinion is supported by pharmaceutical companies, who say that the results "emphasize the persistent nature of excess weight," akin to managing diseases like high blood pressure.
Patient Experiences
People who have come off the jabs describe a powerful resurgence of appetite.
"It was like a trigger that goes on and you become starving," recalled a patient.
The struggle is worsened if individuals have not established sustainable lifestyle or habit changes during treatment.
Significant Adoption
Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Adoption is more common among females than men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
Finally, researchers emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on integrated lifestyle management.